Adam de la Zerda1,2, Shradha Prabhulkar3, Victor L Perez3, Marco Ruggeri3, Amit S Paranjape3, Frezghi Habte1, Sanjiv S Gambhir1,4,5, Richard M Awdeh3. 1. Molecular Imaging Program at Stanford, the Bio-X Program and the Department of Radiology, Stanford University, Palo Alto, California, USA. 2. Department of Structural Biology, Stanford University, Palo Alto, California, USA. 3. Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA. 4. Department of Bioengineering, Stanford University, Palo Alto, California, USA. 5. Department of Materials Science and Engineering, Stanford University, Palo Alto, California, USA.
Abstract
BACKGROUND: Optical coherence tomography (OCT) is a powerful imaging modality to visualize tissue structures, with axial image pixel resolution as high as 1.6 μm in tissue. However, OCT is intrinsically limited to providing structural information as the OCT contrast is produced by optically scattering tissues. METHODS: Gold nanorods (GNRs) were injected into the anterior chamber (AC) and cornea of mice eyes which could create a significant OCT signal and hence could be used as a contrast agent for in vivo OCT imaging. RESULTS: A dose of 30 nM of GNRs (13 nm in diameter and 45 nm in length) were injected to the AC of mice eyes and produced an OCT contrast nearly 50-fold higher than control mice injected with saline. Furthermore, the lowest detectable concentration of GNRs in living mice AC was experimentally estimated to be as low as 120 pM. CONCLUSIONS: The high sensitivity and low toxicity of GNRs brings great promise for OCT to uniquely become a high-resolution molecular imaging modality.
BACKGROUND: Optical coherence tomography (OCT) is a powerful imaging modality to visualize tissue structures, with axial image pixel resolution as high as 1.6 μm in tissue. However, OCT is intrinsically limited to providing structural information as the OCT contrast is produced by optically scattering tissues. METHODS: Gold nanorods (GNRs) were injected into the anterior chamber (AC) and cornea of mice eyes which could create a significant OCT signal and hence could be used as a contrast agent for in vivo OCT imaging. RESULTS: A dose of 30 nM of GNRs (13 nm in diameter and 45 nm in length) were injected to the AC of mice eyes and produced an OCT contrast nearly 50-fold higher than control mice injected with saline. Furthermore, the lowest detectable concentration of GNRs in living mice AC was experimentally estimated to be as low as 120 pM. CONCLUSIONS: The high sensitivity and low toxicity of GNRs brings great promise for OCT to uniquely become a high-resolution molecular imaging modality.
Authors: Willem J M Mulder; Gustav J Strijkers; Jo W Habets; Egbert J W Bleeker; Daisy W J van der Schaft; Gert Storm; Gerben A Koning; Arjan W Griffioen; Klaas Nicolay Journal: FASEB J Date: 2005-10-04 Impact factor: 5.191
Authors: Adam de la Zerda; Sunil Bodapati; Robert Teed; Meike L Schipper; Shay Keren; Bryan R Smith; Johnny S T Ng; Sanjiv Sam Gambhir Journal: Mol Imaging Biol Date: 2009-12-10 Impact factor: 3.488
Authors: Jürgen K Willmann; Ramasamy Paulmurugan; Kai Chen; Olivier Gheysens; Martin Rodriguez-Porcel; Amelie M Lutz; Ian Y Chen; Xiaoyuan Chen; Sanjiv S Gambhir Journal: Radiology Date: 2008-01-07 Impact factor: 11.105
Authors: Yali Jia; Gangjun Liu; Andrew Y Gordon; Simon S Gao; Alex D Pechauer; Jonathan Stoddard; Trevor J McGill; Ashwath Jayagopal; David Huang Journal: Opt Express Date: 2015-02-23 Impact factor: 3.894
Authors: Debasish Sen; Elliott D SoRelle; Orly Liba; Roopa Dalal; Yannis M Paulus; Tae-Wan Kim; Darius M Moshfeghi; Adam de la Zerda Journal: J Biomed Opt Date: 2016-06-01 Impact factor: 3.170